The involvement of O-antigen polysaccharide in lipopolysaccharide in macrophage activation

Anticancer Research

Volumn 32, Issue 6, 2012, Pages 2337-2341

  Shimada, Misato ^a,b   Kadowaki, Takeshi ^b   Taniguchi, Yoshie ^c   Inagawa, Hiroyuki ^b   Okazaki, Kathuichiro ^a   Soma, Gen Ichiro ^b,c  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

C type lectin; Lipopolysaccharide; LPS; O antigen polysaccharide; Review; Toll like receptor

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIUM LIPOPOLYSACCHARIDE; BETA INTERFERON; CD14 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 17; LECTIN RECEPTOR; LIPID A; LIPOPOLYSACCHARIDE BINDING PROTEIN; O ANTIGEN; O ANTIGEN POLYSACCHARIDE; OLIGOSACCHARIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

BIOLOGICAL ACTIVITY; CELL ADHESION; CELL SURFACE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ESCHERICHIA COLI; HUMAN; INTRACELLULAR SIGNALING; MACROPHAGE ACTIVATION; NONHUMAN; PANTOEA AGGLOMERANS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; CHEMISTRY; IMMUNOLOGY; MACROPHAGE; REVIEW;

HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; O ANTIGENS;

EID: 84864549076     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (55)

1. Marshall JC: Lipopolysaccharide: An endotoxin or an exogenous hormone? Clin Infect Dis 41(Suppl 7): S470-480, 2005.
2. Korthals M, Ege MJ, Tebbe CC, von Mutius E and Bauer J: Application of PCR-SSCP for molecular epidemiological studies on the exposure of farm children to bacteria in environmental dust. JMM 73: 49-56, 2008.
3. Inagawa H, Kohchi C and Soma G: Oral administration of lipopolysaccharides for the prevention of various diseases: benefit and usefulness. Anticancer Res 31: 2431-2436, 2011.
4. Raetz CR: Biochemistry of endotoxins. Annu Rev Biochem 59: 129-170, 1990.
5. Raetz CR and Whitfield C: Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635-700, 2002.
6. Suzuki H, Saito H, Sato K and Tomioka H: In vitro and in vivo activities of chemically synthesized lipid A-subunit analogue, JTP3309, against mycobacterial infections in mice and in mouse peritoneal macrophages. Kekkaku [Tuberculosis] 70: 285-292, 1995.
7. Mudd JB and Saltzgaber-Muller J: Fatty acid and complex lipid composition of a Saccharomyces cerevisiae mutant unable to synthesize delta-aminolevulinic acid. Arch Biochem Biophys 186: 359-364, 1978.
8. Galanos C, Lehmann V, Luderitz O, Rietschel ET, Westphal O, Brade H, Brade L, Freudenberg MA, Hansen-Hagge T, Luderitz T, Mckenzie G, Schade U, Strittmatter W, Tanamoto K-I, Zahringer U, Imoto M, Yoshimura H, Yamamoto M, Shimamoto T, Kusumoto S and Shiba T: Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A. Eur J Biochem 140: 221-227, 1984.
9. Tanamoto K, Zahringer U, McKenzie GR, Galanos C, Rietschel ET, Luderitz O, Kusumoto S and Shiba T: Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate. Infect Immun 44: 421-426, 1984.
10. Ingram BO, Masoudi A and Raetz CR: Escherichia coli mutants that synthesize dephosphorylated lipid A molecules. Biochemistry 49: 8325-8337, 2010.
11. Burd RS, Battafarano RJ, Cody CS, Farber MS, Ratz CA and Dunn DL: Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two distinct mechanisms. Ann Surg 218: 250-259, discussion 259-261, 1993.
12. Nagy G, Palkovics T, Otto A, Kusch H, Kocsis B, Dobrindt U, Engelmann S, Hecker M, Emody L, Pal T and Hacker J: "Gently rough": the vaccine potential of a Salmonella enterica regulatory lipopolysaccharide mutant. J Infect Dis 198: 1699-1706, 2008.
13. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Huber M, Kalis C, Keck S, Galanos C, Freudenberg M and Beutler B: CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6: 565-570, 2005.
14. Huber M, Kalis C, Keck S, Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Beutler B, Galanos C and Freudenberg MA: R-form LPS, the master key to the activation of TLR4/MD-2-positive cells. Eur J Immunol 36: 701-711, 2006.
15. Kohchi C, Inagawa H, Nishizawa T, Yamaguchi T, Nagai S and Soma G: Applications of lipopolysaccharide derived from Pantoea agglomerans (IP-PA1) for health care based on macrophage network theory. J Biosc Bioeng 102: 485-496, 2006.
16. Taniguchi Y, Nishizawa T, Honda T, Yoshioka N, Inagawa H, Kohchi C and Soma G: Development and potential use of a monoclonal antibody to the lipopolysaccharide of Pantoea agglomerans (IP-PA1). Anticancer Res 27: 3701-3706, 2007.
17. Hara H, Ishihara C, Takeuchi A, Imanishi T, Xue L, Morris SW, Inui M, Takai T, Shibuya A, Saijo S, Iwakura Y, Ohno N, Koseki H, Yoshida H, Penninger JM and Saito T: The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat Immunol 8: 619-629, 2007.
18. Rogers NC, Slack EC, Edwards AD, Nolte MA, Schulz O, Schweighoffer E, Williams DL, Gordon S, Tybulewicz VL, Brown GD and Reise Sousa C: Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C-type lectins. Immunity 22: 507-517, 2005.
19. Yamasaki S, Ishikawa E, Sakuma M, Hara H, Ogata K and Saito T: Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat Immunol 9: 1179-1188, 2008.
20. Chu CL, Yu YL, Shen KY, Lowell CA, Lanier LL and Hamerman JA: Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRgamma. Eur J Immunol 38: 166-173, 2008.
21. Doyle AG, Herbein G, Montaner LJ, Minty AJ, Caput D, Ferrara P and Gordon S: Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. Eur J Immunol 24: 1441-1445, 1994.
22. DeFife KM, Jenney CR, McNally AK, Colton E and Anderson JM: Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J Immunol 158: 3385-3390, 1997.
23. Leteux C, Chai W, Loveless RW, Yuen CT, Uhlin-Hansen L, Combarnous Y, Jankovic M, Maric SC, Misulovin Z, Nussenzweig MC and Feizi T: The cysteine-rich domain of the macrophage mannose receptor is a multispecific lectin that recognizes chondroitin sulfates A and B and sulfated oligosaccharides of blood group Lewis(a) and Lewis(x) types in addition to the sulfated N-glycans of lutropin. J Exp Med 191: 1117-1126, 2000.
24. Martinez-Pomares L, Reid DM, Brown GD, Taylor PR, Stillion RJ, Linehan SA, Zamze S, Gordon S and Wong SY: Analysis of mannose receptor regulation by IL-4, IL-10, and proteolytic processing using novel monoclonal antibodies. J Leuk Biol 73: 604-613, 2003.
25. van Kooyk Y and Geijtenbeek TB: DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 3: 697-709, 2003.
26. Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y and Geijtenbeek TB: C-type lectin DC-SIGN modulates toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 26: 605-616, 2007.
27. Soilleux EJ, Morris LS, Leslie G, Chehimi J, Luo Q, Levroney E, Trowsdale J, Montaner LJ, Doms RW, Weissman D, Coleman N and Lee B: Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro . J Leuk Biol 71: 445-457, 2002.
28. Nagaoka K, Takahara K, Tanaka K, Yoshida H, Steinman RM, Saitoh S, Akashi-Takamura S, Miyake K, Kang YS, Park CG and Inaba K: Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in gram-negative bacteria. Int Immunol 17: 827-836, 2005.
29. Saunders SP, Barlow JL, Walsh CM, Bellsoi A, Smith P, McKenzie AN and Fallon PG: C-type lectin SIGN-R1 has a role in experimental colitis and responsiveness to lipopolysaccharide. J Immunol 184: 2627-2637, 2010.
30. Sato M, Kawakami K, Osawa T and Toyoshima S: Molecular cloning and expression of cDNA encoding a galactose/N-acetylgalactosamine-specific lectin on mouse tumoricidal macrophages. J Biochem 111: 331-336, 1992.
31. Ma BY, Kaihama M, Nonaka M, Oka S, Kawasaki N and Kawasaki T: LPS suppresses expression of asialoglycoprotein-binding protein through TLR4 in thioglycolate-elicited peritoneal macrophages. Glycoconj J 24: 243-249, 2007.
32. Willment JA, Lin HH, Reid DM, Taylor PR, Williams DL, Wong SY, Gordon S and Brown GD: Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J Immunol 171: 4569-4573, 2003.
33. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS and Gordon S: Dectin-1 mediates the biological effects of betaglucans. J Exp Med 197: 1119-1124, 2003.
34. Gantner BN, Simmons RM, Canavera SJ, Akira S and Underhill DM: Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2. J Exp Med 197: 1107-1117, 2003.
35. Matsumoto M, Tanaka T, Kaisho T, Sanjo H, Copeland NG, Gilbert DJ, Jenkins NA and Akira S: A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages. J Immunol 163: 5039-5048, 1999.
36. Rosseau S, Hocke A, Mollenkopf H, Schmeck B, Suttorp N, Kaufmann SH and Zerrahn J: Comparative transcriptional profiling of the lung reveals shared and distinct features of Streptococcus pneumoniae and influenza A virus infection. Immunology 120: 380-391, 2007.
37. Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H, Takeuchi O, Kinoshita T, Akira S, Yoshikai Y and Yamasaki S: Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin mincle. J Exp Med 206: 2879-2888, 2009.
38. Schoenen H, Bodendorfer B, Hitchens K, Manzanero S, Werninghaus K, Nimmerjahn F, Agger EM, Stenger S, Andersen P, Ruland J, Brown GD, Wells C and Lang R: Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J Immunol 184: 2756-2760, 2010.
39. Benoit M, Desnues B and Mege JL: Macrophage polarization in bacterial infections. J Immunol 181: 3733-3739, 2008.
40. Mege JL, Mehraj V and Capo C: Macrophage polarization and bacterial infections. Curr Opini Infecti 24: 230-234, 2011.
41. MacDonald TT: The mucosal immune system. Parasite Immunol 25: 235-246, 2003.
42. Kiyono H and Okada K: Mucosal immune systems-frontline of the biological defence mechanism. Nihon Jibiinkoka Gakkai Kaiho 114: 843-850, 2011.
43. Rugtveit J, Nilsen EM, Bakka A, Carlsen H, Brandtzaeg P and Scott H: Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflam Bowel Dis Gastroenterology 112: 1493-1505, 1997.
44. Mahida YR: The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflammatory Bowel Diseases 6: 21-33, 2000.
45. Nakata K, Inagawa H, Nishizawa T, Kohchi C and Soma GI: Specific messenger RNA expression for signal transduction molecules by lipopolysaccharide in intestinal macrophages. Clin Exp Immunol 143: 484-493, 2006.
46. Smith PD, Smythies LE, Mosteller-Barnum M, Sibley DA, Russell MW, Merger M, Sellers MT, Orenstein JM, Shimada T, Graham MF and Kubagawa H: Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 167: 2651-2656, 2001.
47. Nakata K, Inagawa H, Nishizawa T, Kohchi C and Soma G: Suppression of response to foreign substances by intestinal macrophages. Anticancer Res 27: 3723-3727, 2007.
48. Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, Orenstein JM and Smith PD: Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115: 66-75, 2005.
49. Yoshioka N, Taniguchi Y, Yoshida A, Nakata K, Nishizawa T, Inagawa H, Kohchi C and Soma G: Intracellular localization of CD14 protein in intestinal macrophages. Anticancer Res 29: 865-869, 2009.
50. Inagawa H, Nishizawa T, Noguchi K, Minamimura M, Takagi K, Goto S, Soma G and Mizuno D: Anti tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system. Anticancer Res 17: 2153-2158, 1997.
51. Iguchi M, Inagawa H, Nishizawa T, Okutomi T, Morikawa A, Soma GI and Mizuno D: Homeostasis as regulated by activated macrophage. V. Suppression of diabetes mellitus in non-obese diabetic mice by LPSw (a lipopolysaccharide from wheat flour). Chem Pharm Bull 40: 1004-1006, 1992.
52. Inagawa H, Saitoh F, Iguchi M, Nishizawa T, Okutomi T, Morikawa A, Soma GI and Mizuno D: Homeostasis as regulated by activated macrophage. III. Protective effect of LPSw (lipopolysaccharide (LPS) of wheat flour) on gastric ulcer in mice as compared with those of other LPS from various sources. Chem Pharm Bull 40: 998-1000, 1992.
53. Okutomi T, Nishizawa T, Inagawa H, Takano T, Morikawa A, Soma G and Mizuno D: Homeostasis as regulated by activated macrophage. VII. Suppression of serum cholesterol level by LPSw (a lipopolysaccharide from wheat flour) in WHHL (Watanabe heritable hyperlipidemic) rabbit. Chem Pharm Bull 40: 1268-1270, 1992.
54. Nakata K, Inagawa H, Nishizawa T, Honda T, Kohchi C, Tonomoto Y, Yoshimura H, Nagasue N, Natori S, Terada H and Soma G: Inherent potential for production of tumor necrosis factor-alpha by human intestinal macrophages. Int J Colorectal Dis 21: 339-347, 2006.
55. Nakata K, Inagawa H, Nishizawa T, Kohchi C, Taniguchi Y, Yoshioka N and Soma G: Unique molecular characteristics of the environmental responses of mucosal macrophages. Anticancer Res 26: 4009-4014, 2006.